Lillia unveils AI platform for chronic disease management
Lillia, an AI startup for chronic care, on Tuesday, introduced its platform for individuals living with diabetes and related chronic conditions to live fulfilling lives.
Trump-Modi Meet
The mega MIGA, MAGA plans of India's Modi and US' Trump
Trump says India has more tariffs than others
Trump's 'golden rule' for imposing reciprocal tariffs
Lillia’s clinically proven, AI-powered platform enables healthcare providers, insurers, corporations and public sector entities to manage chronic diseases effectively.
Sujit Chakrabarty, Lillia’s founder and CEO, said in a statement, “Diabetes and related chronic conditions is the world’s biggest healthcare challenge affecting more than 500 million people. The good news is with the right interventions, diabetes can be prevented and reversed in the early stages, or effectively managed for long-term health. Lillia exists to lower the chronic disease burden for the world by providing continuous adaptive care that drives a real and lasting lifestyle change.”
Lillia leverages AI, paired with expert human coaches—psychologists, nutritionists and doctors, to create a care journey hyperlocalised to an individual’s metabolism and lifestyle. It guides them to develop long-lasting micro-habits backed by proven clinical outcomes.
At Web Summit Qatar, Lillia also unveiled its vision of a chronic care digital twin paired with AI agents to bring predictive capabilities to the platform and unlock applications in real-time risk monitoring and precision medication, among other use cases.
Artific
